In this context, a recent study has demonstrated that targeting STAT3 with a small molecule inhibitor can suppress ovarian cancer growth and potentiate the effect of cisplatin in a mouse xenograft model [51]. This evidence concerns the gene STAT3 and ovarian cancer.